Open Access
Issue
BIO Web Conf.
Volume 174, 2025
2025 7th International Conference on Biotechnology and Biomedicine (ICBB 2025)
Article Number 02004
Number of page(s) 4
Section Innovations in Therapeutics and Disease Mechanisms
DOI https://doi.org/10.1051/bioconf/202517402004
Published online 12 May 2025
  • Cheng, Z., Li, M., Dey, R., Chen, Y. (2021) Nanomaterials for cancer therapy: current progress and perspectives. J. Hematol. Oncol., 14:85. [CrossRef] [Google Scholar]
  • Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., Xia, Y. (2014) Engineered nanoparticles for drug delivery in cancer therapy. Angew. Chem. Int. Ed. Engl., 53:12320-64. [CrossRef] [PubMed] [Google Scholar]
  • Zhou, M., Zhao, Q. F., Wu, Y. F., Feng, S., Wang, D., Zhang, Y., Wang, S.L. (2020) Mesoporous carbon nanoparticles as multi-functional carriers for cancer therapy compared with mesoporous silica nanoparticles. AAPS PharmSciTech., 21:42. [CrossRef] [Google Scholar]
  • Peng, L., Peng, H., Li, W., Zhao, D. (2023). Monomicellar assembly to synthesize structured and functional mesoporous carbonaceous nanomaterials. Nature protocols, 18(4), 1155–1178. [CrossRef] [PubMed] [Google Scholar]
  • Li, X., Yan, Y., Lin, Y. Z., Jiao, J., Wang, D., Di, D. H., Zhang, Y., Jiang, T. Y., Zhao, Q.F, Wang, S.L. (2017) Hollow mesoporous carbon as a near-infrared absorbing carrier compared with mesoporous carbon nanoparticles for chemo-photothermal therapy. J. Colloid Interface Sci., 494:159-169. [CrossRef] [Google Scholar]
  • Fan, C. H., Kong, F. H., Shetti, D., Zhang, B., Yang, Y. G., Wei, K. (2019) Resveratrol loaded oxidized mesoporous carbon nanoparticles: A promising tool to treat triple negative breast cancer. Biochem. Biophys. Res. Commun., 519:378-384. [CrossRef] [Google Scholar]
  • Bhosale, S. R., Bhosale, R. R., Patil, D. N., Dhavale, R. P., Kolekar, G. B., Shimpale, V. B., Anbhule, P.V. (2023) Bioderived mesoporous carbon@tungsten oxide nanocomposite as a drug carrier vehicle of doxorubicin for potent cancer therapy. Langmuir, 39:11910-11924. [CrossRef] [PubMed] [Google Scholar]
  • Luo, J., Wan, L., Zhang, Q. Y., Cui, B. F., Li, C., Jiang, Y., Jiang, M.yY., Wang, K.K. (2023) Constructing a drug release model by central composite design to investigate the interaction between drugs and temperature-sensitive controlled release nanoparticles. Eur. J. Pharm. Biopharm., 183:24-32. [CrossRef] [Google Scholar]
  • Zhang, Y. Z., Zhu, W. F., Zhang, H. R., Han, J., Zhang, L. H., Lin, Q. S., Ai, F.W. (2017) Carboxymethyl chitosan/phospholipid bilayer-capped mesoporous carbon nanoparticles with pH-responsive and prolonged release properties for oral delivery of the antitumor drug, Docetaxel. Int. J. Pharm., 532:384-392. [CrossRef] [Google Scholar]
  • Wang, L. P., Wang, W. B., Wang, Y. F., Tao, W. L., Hou, T. X., Cai, D. F., Liu, L. K., Liu, C., Jiang, K., Lin, J. Y., Zhang, Y. J., Zhu, W. Q., Han, C.Y. (2024) The graphene quantum dots gated nanoplatform for photothermal-enhanced synergetic tumor therapy. Molecules, 29:615. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.